180869-39-0 Usage
General Description
4-Pyrimidinecarboxaldehyde, 2-(methylamino)- (9CI) is a chemical compound with the molecular formula C7H8N4O. It is a derivative of pyrimidine and contains an aldehyde functional group and a methylamino group. 4-Pyrimidinecarboxaldehyde, 2-(methylamino)- (9CI) is commonly used as a building block in organic synthesis, particularly in the pharmaceutical industry for the production of various drugs and pharmaceutical intermediates. It is also used in the development of agrochemicals and other specialty chemicals. Additionally, 4-Pyrimidinecarboxaldehyde, 2-(methylamino)- (9CI) may have potential uses in research and scientific applications due to its unique chemical structure and properties. However, it is important to handle this chemical with care, as it may have potential hazards and should be used in accordance with safety protocols and regulations.
Check Digit Verification of cas no
The CAS Registry Mumber 180869-39-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,0,8,6 and 9 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 180869-39:
(8*1)+(7*8)+(6*0)+(5*8)+(4*6)+(3*9)+(2*3)+(1*9)=170
170 % 10 = 0
So 180869-39-0 is a valid CAS Registry Number.
InChI:InChI=1/C6H7N3O/c1-7-6-8-3-2-5(4-10)9-6/h2-4H,1H3,(H,7,8,9)
180869-39-0Relevant articles and documents
NEW THIENOPYRIMIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
-
, (2015/07/15)
Compounds of formula (I): wherein R1, R2, R3, R4, R5, R6, R7, R12, X, A and n are as defined in the description.
INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING IκB KINASE
-
Page/Page column 19, (2010/11/30)
The invention relates to compounds of formula (I). Said compounds are suitable for producing medicaments for the prophylaxis and treatment of diseases, the progression of which involves increased activity of IκB kinase.
Pyrimidinylimidazole inhibitors of CSBP/P38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes
Adams, Jerry L.,Boehm, Jeffrey C.,Kassis, Shouki,Gorycki, Peter D.,Webb, Edward F.,Hall, Ralph,Sorenson, Margaret,Lee, John C.,Ayrton, Andrew,Griswold, Don E.,Gallagher, Timothy F.
, p. 3111 - 3116 (2007/10/03)
Pyrimidine analogs of the pyridinylimidazole class of CSBP/p38 kinase inhibitors were prepared in an effort to reduce the potent inhibition of hepatic cytochrome P450 observed for the pyridinyl compounds. The substitution of pyrimidin-4-yl, 2-methoxypyrimidin-4-yl, or 2- methylaminopyrimidin-4-yl for pyridin-4-yl effectively dissociates CSBP/p38 kinase from P450 inhibition for this series and furthermore achieves an increase in oral activity.
